최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of the American Academy of Dermatology, v.80 no.6, 2019년, pp.1497 - 1506
Bienenfeld, Amanda (New York University School of Medicine) , Azarchi, Sarah (New York University School of Medicine) , Lo Sicco, Kristen (The Ronald O. Perelman Department of Dermatology, New York University School of Medicine) , Marchbein, Shari (The Ronald O. Perelman Department of Dermatology, New York University School of Medicine) , Shapiro, Jerry (The Ronald O. Perelman Department of Dermatology, New York University School of Medicine) , Nagler, Arielle R. (The Ronald O. Perelman Department of Dermatology, New York University School of Medicine)
Androgens are produced throughout the body in steroid-producing organs, such as the adrenal glands and ovaries, and in other tissues, like the skin. Several androgens are found normally in women, including dehydroepiandrosterone, dehydroepiandrosterone-sulfate, testosterone, dihydrotestosterone, and...
J Steroid Biochem Mol Biol Slominski 137 107 2013 10.1016/j.jsbmb.2013.02.006 Steroidogenesis in the skin: implications for local immune functions
J Invest Dermatol Thiboutot 120 905 2003 10.1046/j.1523-1747.2003.12244.x Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1)
Best Pract Res Clin Obstet Gynaecol Lizneva 37 98 2016 10.1016/j.bpobgyn.2016.05.003 Androgen excess: investigations and management
J Am Acad Dermatol Sperling 28 669 1993 10.1016/0190-9622(93)70092-8 Androgen biology as a basis for the diagnosis and treatment of androgenic disorders in women. I
Clin Dermatol Essah 24 289 2006 10.1016/j.clindermatol.2006.04.004 Dermatology of androgen-related disorders
Steroids Slominski 103 72 2015 10.1016/j.steroids.2015.04.006 On the role of skin in the regulation of local and systemic steroidogenic activities
Clin Endocrinol Metab Longcope 15 213 1986 10.1016/S0300-595X(86)80021-4 Adrenal and gonadal androgen secretion in normal females
J Am Acad Dermatol Lookingbill 12 481 1985 10.1016/S0190-9622(85)70067-9 Tissue production of androgens in women with acne
Horm Metab Res Zouboulis 39 85 2007 10.1055/s-2007-961807 Sexual hormones in human skin
Dermatology Zouboulis 196 21 1998 10.1159/000017861 The human sebocyte culture model provides new insights into development and management of seborrhoea and acne
Endocr Rev Slominski 34 827 2013 10.1210/er.2012-1092 Key role of CRF in the skin stress response system
Fertil Steril Burger 77 suppl 4 S3 2002 10.1016/S0015-0282(02)02985-0 Androgen production in women
Metabolism Vierhapper 52 927 2003 10.1016/S0026-0495(03)00060-X Production rates of testosterone and of dihydrotestosterone in female pattern hair loss
J Endocrinol Choudhry 133 467 1992 10.1677/joe.0.1330467 Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands
J Invest Dermatol Liang 100 663 1993 10.1111/1523-1747.ep12472330 Immunocytochemical localization of androgen receptors in human skin using monoclonal antibodies against the androgen receptor
J Dtsch Dermatol Ges Degitz 5 316 2007 10.1111/j.1610-0387.2007.06274.x Pathophysiology of acne
Endocr Rev Deplewski 21 363 2000 10.1210/edrv.21.4.0404 Role of hormones in pilosebaceous unit development
Arch Dermatol Res Lai 304 499 2012 10.1007/s00403-012-1265-x The role of androgen and androgen receptor in skin-related disorders
Br J Dermatol Bhate 168 474 2013 10.1111/bjd.12149 Epidemiology of acne vulgaris
Skin Pharmacol Physiol Holzmann 27 suppl 1 3 2014 10.1159/000354887 Postadolescent acne in females
J Am Acad Dermatol Goulden 41 577 1999 Prevalence of facial acne in adults
Br J Dermatol Ramos-e-Silva 172 suppl 1 20 2015 10.1111/bjd.13638 Acne in women
J Am Acad Dermatol Housman 71 847.e1 2014 10.1016/j.jaad.2014.05.007 Polycystic ovary syndrome: a review for dermatologists: part I. Diagnosis and manifestations
J Am Acad Dermatol Schmidt 73 672 2015 10.1016/j.jaad.2015.05.026 Evidence-based approach to cutaneous hyperandrogenism in women
Br J Dermatol Bettoli 172 suppl 1 37 2015 10.1111/bjd.13681 Is hormonal treatment still an option in acne today?
J Clin Endocrinol Metab Imperato-McGinley 76 524 1993 The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity
Med Clin North Am Lolis 93 1161 2009 10.1016/j.mcna.2009.08.008 Acne and systemic disease
J Invest Dermatol Thiboutot 105 209 1995 10.1111/1523-1747.ep12317162 Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin
Med Electron Microsc Toyoda 34 29 2001 10.1007/s007950100002 Pathogenesis of acne
Best Pract Res Clin Endocrinol Metab Yildiz 20 167 2006 10.1016/j.beem.2006.02.004 Diagnosis of hyperandrogenism: clinical criteria
J Invest Dermatol Thiboutot 123 1 2004 10.1111/j.1523-1747.2004.t01-2-.x Regulation of human sebaceous glands
J Invest Dermatol Fluhr 117 44 2001 10.1046/j.0022-202x.2001.01399.x Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity
J Invest Dermatol Elias 125 183 2005 10.1111/j.0022-202X.2005.23668.x Stratum corneum defensive functions: an integrated view
Fertil Steril Slayden 75 889 2001 10.1016/S0015-0282(01)01701-0 Hyperandrogenemia in patients presenting with acne
Arch Dermatol Reingold 123 209 1987 10.1001/archderm.1987.01660260079018 The relationship of mild hirsutism or acne in women to androgens
Dermatology da Cunha 226 167 2013 10.1159/000347196 Androgenic hormone profile of adult women with acne
Clin Dermatol Barros 35 168 2017 10.1016/j.clindermatol.2016.10.009 Hormonal therapies for acne
Clin Dermatol Katsambas 28 17 2010 10.1016/j.clindermatol.2009.03.006 Hormonal therapy for acne: why not as first line therapy? Facts and controversies
Obstet Gynecol Azziz 101 995 2003 The evaluation and management of hirsutism
Dermatol Ther Somani 21 376 2008 10.1111/j.1529-8019.2008.00219.x The clinical evaluation of hirsutism
J Clin Endocrinol Metab Ferriman 21 1440 1961 10.1210/jcem-21-11-1440 Clinical assessment of body hair growth in women
Endocr Pract Goodman 7 120 2001 10.4158/EP.7.2.120 American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders
Dermatol Ther Randall 21 314 2008 10.1111/j.1529-8019.2008.00214.x Androgens and hair growth
J Clin Endocrinol Metab Martin 103 1233 2018 10.1210/jc.2018-00241 Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline
Am J Obstet Gynecol Souter 191 1914 2004 10.1016/j.ajog.2004.06.064 The prevalence of androgen excess among patients with minimal unwanted hair growth
Hum Reprod Update Escobar-Morreale 18 146 2012 10.1093/humupd/dmr042 Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society
N Engl J Med Rosenfield 353 2578 2005 10.1056/NEJMcp033496 Clinical practice. Hirsutism
J Clin Endocrinol Metab Azziz 89 453 2004 10.1210/jc.2003-031122 Androgen excess in women: experience with over 1000 consecutive patients
Dermatoendocrinol Chen 1 81 2009 10.4161/derm.1.2.8354 Hormones and the pilosebaceous unit
N Engl J Med Shapiro 357 1620 2007 10.1056/NEJMcp072110 Clinical practice. Hair loss in women
Br J Dermatol Birch 154 85 2006 10.1111/j.1365-2133.2005.06953.x Female pattern hair loss, sebum excretion and the end-organ response to androgens
J Am Acad Dermatol Futterweit 19 831 1988 10.1016/S0190-9622(88)70241-8 The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia
Br J Dermatol Mirmirani 165 suppl 3 7 2011 10.1111/j.1365-2133.2011.10629.x Hormonal changes in menopause: do they contribute to a ‘midlife hair crisis’ in women?
Exp Dermatol Zouboulis 13 suppl 4 5 2004 10.1111/j.1600-0625.2004.00255.x Androgen action on human skin - from basic research to clinical significance
J Invest Dermatol Millar 118 216 2002 10.1046/j.0022-202x.2001.01670.x Molecular mechanisms regulating hair follicle development
J Invest Dermatol Shimizu 122 239 2004 10.1046/j.0022-202X.2004.22224.x Wnt signaling through the beta-catenin pathway is sufficient to maintain, but not restore, anagen-phase characteristics of dermal papilla cells
Br J Dermatol Leiros 166 1035 2012 10.1111/j.1365-2133.2012.10856.x Hair follicle stem cell differentiation is inhibited through cross-talk between Wnt/beta-catenin and androgen signalling in dermal papilla cells from patients with androgenetic alopecia
Br J Dermatol Ali 164 508 2011 Physiological changes in scalp, facial and body hair after the menopause: a cross-sectional population-based study of subjective changes
Clin Endocrinol (Oxf) Rothman 75 160 2011 10.1111/j.1365-2265.2011.04040.x How should postmenopausal androgen excess be evaluated?
Br J Dermatol Birch 144 297 2001 10.1046/j.1365-2133.2001.04018.x Hair density, hair diameter and the prevalence of female pattern hair loss
Eur J Endocrinol Markopoulos 172 R79 2015 10.1530/EJE-14-0468 Hyperandrogenism after menopause
Eur J Endocrinol Sarfati 165 779 2011 10.1530/EJE-11-0542 Impact of clinical, hormonal, radiological, and immunohistochemical studies on the diagnosis of postmenopausal hyperandrogenism
Fertil Steril Fauser 97 28 2012 10.1016/j.fertnstert.2011.09.024 Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
Eur J Obstet Gynecol Reprod Biol Uysal 211 21 2017 10.1016/j.ejogrb.2017.01.054 Is acne a sign of androgen excess disorder or not?
Endocr Pract Goodman 21 1291 2015 10.4158/EP15748.DSC American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: guide to the best practices in the evaluation and treatment of polycystic ovarian syndrome-part 1
J Am Acad Dermatol Zaenglein 74 945 2016 10.1016/j.jaad.2015.12.037 Guidelines of care for the management of acne vulgaris
J Am Acad Dermatol Sperling 28 901 1993 10.1016/0190-9622(93)70129-H Androgen biology as a basis for the diagnosis and treatment of androgenic disorders in women. II
J Am Acad Dermatol Gollnick 49 S1 2003 10.1067/mjd.2003.618 Management of acne: a report from a Global Alliance to Improve Outcomes in Acne
Medicine (Baltimore) Karrer-Voegeli 88 32 2009 10.1097/md.0b013e3181946a2c Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism
Skinmed Clark 12 84 2014 Dermatologic manifestation of hyperandrogenism: a retrospective chart review
Endocr Rev Azziz 21 347 2000 Idiopathic hirsutism
J Clin Endocrinol Metab Rosner 92 405 2007 10.1210/jc.2006-1864 Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement
Arch Gynecol Obstet Hassa 274 227 2006 10.1007/s00404-006-0173-8 Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
Hum Reprod 19 41 2004 10.1093/humrep/deh098 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
Reed 2000 Endotext The normal menstrual cycle and the control of ovulation
J Clin Endocrinol Metab Carmina 91 2 2006 10.1210/jc.2005-1457 Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism
Fertil Steril Glintborg 82 1570 2004 10.1016/j.fertnstert.2004.06.040 Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis
Fertil Steril 86 5 suppl 1 S241 2006 The evaluation and treatment of androgen excess
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.